{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T10:20:53Z","timestamp":1789640453647,"version":"4.0.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004702","name":"Universit\u00e0 degli Studi di Genova","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004702","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Suppressor of cytokine signaling 1 (SOCS1) haploinsufficiency is a recently described inborn error of immunity characterized by autoimmunity, inflammation, lymphoproliferation, and increased infection susceptibility. SOCS1, a negative regulator of cytokine signaling via the JAK\/STAT pathway, explains the condition\u2019s broad phenotypic variability. Single nucleotide polymorphisms in SOCS1 have been linked to multiple sclerosis (MS), and SOCS1 mimetics have shown efficacy in MS animal models. However, neurological involvement has not been previously reported in patients with SOCS1 insufficiency. We describe a family with a heterozygous SOCS1 variant, highlighting neurological manifestations such as MS, autoimmune encephalitis, and recurrent complex regional pain syndrome as novel features. Next-Generation Sequencing and segregation analysis were performed on PBMCs from patients and healthy donors. Functional studies included luciferase reporter assays in HeLa cells expressing the SOCS1 mutant, flow cytometry for phenotypic analysis, and gene expression profiling of the type-I interferon (IFN) signature. Intraepidermal nerve fiber density was evaluated via immunohistochemistry on skin biopsy. Genetic analysis confirmed the variant\u2019s inheritance. Transfected cells carrying the SOCS1 variant showed increased STAT1 transcriptional activity after IFN-\u03b3 stimulation. Elevated STAT5 phosphorylation and T-cell proliferation were observed in response to IL-2. Peripheral blood revealed an elevated IFN signature during relapse. Skin biopsy showed reduced intraepidermal nerve fiber density. This report expands the clinical spectrum of SOCS1-related disorders to include neurological symptoms, emphasizing SOCS1\u2019s critical role in regulating inflammation in the central and peripheral nervous systems.<\/jats:p>","DOI":"10.1007\/s10875-025-01958-z","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:43:02Z","timestamp":1763426582000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Neurological Phenotypes of SOCS1 Haploinsufficiency: Insights from Functional and Histological Investigations"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7670-6825","authenticated-orcid":false,"given":"Serena","family":"Palmeri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0877-6255","authenticated-orcid":false,"given":"Ignazia","family":"Prigione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5868-7699","authenticated-orcid":false,"given":"Francesca","family":"Schena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Jeanpierre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8317-9584","authenticated-orcid":false,"given":"Arinna","family":"Bertoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8437-3466","authenticated-orcid":false,"given":"Federica","family":"Penco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7498-209X","authenticated-orcid":false,"given":"Paola","family":"Bocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7272-7776","authenticated-orcid":false,"given":"Genny","family":"Del Zotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9938-8163","authenticated-orcid":false,"given":"Sara","family":"Massucco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Consuelo","family":"Venturi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Schenone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3259-4718","authenticated-orcid":false,"given":"Gino","family":"Tripodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1772-9504","authenticated-orcid":false,"given":"Giada","family":"Recchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4900-6908","authenticated-orcid":false,"given":"Marina","family":"Lanciotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9816-1704","authenticated-orcid":false,"given":"Maurizio","family":"Miano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3710-0569","authenticated-orcid":false,"given":"Caterina","family":"Matucci-Cerinic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7083-448X","authenticated-orcid":false,"given":"Gianmaria","family":"Viglizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9626-5470","authenticated-orcid":false,"given":"Riccardo","family":"Papa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7858-7866","authenticated-orcid":false,"given":"Fr\u00e9d\u00e9ric","family":"Rieux-Laucat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0131-7846","authenticated-orcid":false,"given":"Roberta","family":"Caorsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0704-1916","authenticated-orcid":false,"given":"Marco","family":"Gattorno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7129-868X","authenticated-orcid":false,"given":"Stefano","family":"Volpi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"issue":"1","key":"1958_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18925-4","volume":"11","author":"J Hadjadj","year":"2020","unstructured":"Hadjadj J, Castro CN, Tusseau M, et al. Early-onset autoimmunity associated with SOCS1 haploinsufficiency. Nat Commun. 2020;11(1):5341. https:\/\/doi.org\/10.1038\/s41467-020-18925-4.","journal-title":"Nat Commun"},{"key":"1958_CR2","doi-asserted-by":"publisher","unstructured":"Thaventhiran JED, Lango Allen H, Burren OS et al. Whole-genome sequencing of a sporadic primary immunodeficiency cohort [published correction appears in Nature. 2020;584(7819):E2. doi: 10.1038\/s41586-020-2556-6]. Nature. 2020;583(7814):90\u201395. https:\/\/doi.org\/10.1038\/s41586-020-2265-1","DOI":"10.1038\/s41586-020-2265-1"},{"issue":"4","key":"1958_CR3","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.rdc.2023.06.003","volume":"49","author":"M Liu","year":"2023","unstructured":"Liu M, Hsu E, Du Y, Lee PY. Suppressor of cytokine signaling 1 haploinsufficiency: A new driver of autoimmunity and immunodysregulation. Rheum Dis Clin North Am. 2023;49(4):757\u201372. https:\/\/doi.org\/10.1016\/j.rdc.2023.06.003.","journal-title":"Rheum Dis Clin North Am"},{"issue":"6","key":"1958_CR4","doi-asserted-by":"publisher","first-page":"e391","DOI":"10.1016\/S2665-9913(24)00348-5","volume":"7","author":"J Hadjadj","year":"2025","unstructured":"Hadjadj J, Wolfers A, Borisov O, SOCS1 Study Group, et al. Clinical manifestations, disease penetrance, and treatment in individuals with SOCS1 insufficiency: a registry-based and population-based study. Lancet Rheumatol. 2025;7(6):e391\u2013402. https:\/\/doi.org\/10.1016\/S2665-9913(24)00348-5.","journal-title":"Lancet Rheumatol"},{"issue":"5","key":"1958_CR5","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1093\/emboj\/18.5.1309","volume":"18","author":"H Yasukawa","year":"1999","unstructured":"Yasukawa H, Misawa H, Sakamoto H, et al. The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop. EMBO J. 1999;18(5):1309\u201320. https:\/\/doi.org\/10.1093\/emboj\/18.5.1309.","journal-title":"EMBO J"},{"issue":"6636","key":"1958_CR6","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/43213","volume":"387","author":"TA Endo","year":"1997","unstructured":"Endo TA, Masuhara M, Yokouchi M, et al. A new protein containing an SH2 domain that inhibits JAK kinases. Nature. 1997;387(6636):921\u20134. https:\/\/doi.org\/10.1038\/43213.","journal-title":"Nature"},{"issue":"1","key":"1958_CR7","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1073\/pnas.95.1.114","volume":"95","author":"DJ Hilton","year":"1998","unstructured":"Hilton DJ, Richardson RT, Alexander WS, et al. Twenty proteins containing a C-terminal SOCS box form five structural classes. Proc Natl Acad Sci U S A. 1998;95(1):114\u20139. https:\/\/doi.org\/10.1073\/pnas.95.1.114.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1958_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.680334","volume":"12","author":"J K\u00f6rholz","year":"2021","unstructured":"K\u00f6rholz J, Gabrielyan A, Sowerby JM, et al. One gene, many facets: multiple immune pathway dysregulation in SOCS1 haploinsufficiency. Front Immunol. 2021;12:680334. https:\/\/doi.org\/10.3389\/fimmu.2021.680334.","journal-title":"Front Immunol"},{"issue":"5","key":"1958_CR9","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.jaci.2020.07.033","volume":"146","author":"PY Lee","year":"2020","unstructured":"Lee PY, Platt CD, Weeks S, et al. Immune dysregulation and multisystem inflammatory syndrome in children (MIS-C) in individuals with haploinsufficiency of SOCS1. J Allergy Clin Immunol. 2020;146(5):1194\u2013e12001. https:\/\/doi.org\/10.1016\/j.jaci.2020.07.033.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"1958_CR10","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1007\/s10875-023-01495-7","volume":"43","author":"M Rodari","year":"2023","unstructured":"Rodari M, Cazals-Hatem D, Uzzan M, et al. Insights into the expanding intestinal phenotypic spectrum of SOCS1 haploinsufficiency and therapeutic options. J Clin Immunol. 2023;43(6):1403\u201313. https:\/\/doi.org\/10.1007\/s10875-023-01495-7.","journal-title":"J Clin Immunol"},{"issue":"8","key":"1958_CR11","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1007\/s10875-022-01346-x","volume":"42","author":"TF Michniacki","year":"2022","unstructured":"Michniacki TF, Walkovich K, DeMeyer L, et al. SOCS1 haploinsufficiency presenting as severe enthesitis, bone marrow hypocellularity, and refractory thrombocytopenia in a pediatric patient with subsequent response to JAK inhibition. J Clin Immunol. 2022;42(8):1766\u201377. https:\/\/doi.org\/10.1007\/s10875-022-01346-x.","journal-title":"J Clin Immunol"},{"issue":"1","key":"1958_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-023-01635-z","volume":"44","author":"C Gruber","year":"2023","unstructured":"Gruber C, Lee A, Buta S, et al. IL4R\u03b1 and IL17A blockade rescue autoinflammation in SOCS1 haploinsufficiency. J Clin Immunol. 2023;44(1):36. https:\/\/doi.org\/10.1007\/s10875-023-01635-z.","journal-title":"J Clin Immunol"},{"issue":"8","key":"1958_CR13","doi-asserted-by":"publisher","first-page":"5077","DOI":"10.4049\/jimmunol.175.8.5077","volume":"175","author":"MG Mujtaba","year":"2005","unstructured":"Mujtaba MG, Flowers LO, Patel CB, Patel RA, Haider MI, Johnson HM. Treatment of mice with the suppressor of cytokine signaling-1 mimetic peptide, tyrosine kinase inhibitor peptide, prevents development of the acute form of experimental allergic encephalomyelitis and induces stable remission in the chronic relapsing\/remitting form. J Immunol. 2005;175(8):5077\u201386. https:\/\/doi.org\/10.4049\/jimmunol.175.8.5077.","journal-title":"J Immunol"},{"key":"1958_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.558341","volume":"11","author":"S Huang","year":"2020","unstructured":"Huang S, Liu K, Cheng A, et al. Socs proteins participate in the regulation of innate immune response caused by viruses. Front Immunol. 2020;11:558341. https:\/\/doi.org\/10.3389\/fimmu.2020.558341.","journal-title":"Front Immunol"},{"issue":"1","key":"1958_CR15","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/gene.2011.44","volume":"13","author":"K Vandenbroeck","year":"2012","unstructured":"Vandenbroeck K, Alvarez J, Swaminathan B, et al. A cytokine gene screen uncovers SOCS1 as genetic risk factor for multiple sclerosis. Genes Immun. 2012;13(1):21\u20138. https:\/\/doi.org\/10.1038\/gene.2011.44.","journal-title":"Genes Immun"},{"issue":"3","key":"1958_CR16","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1007\/s12031-018-1046-x","volume":"64","author":"M Sokratous","year":"2018","unstructured":"Sokratous M, Dardiotis E, Bellou E, et al. CpG island methylation patterns in relapsing-remitting multiple sclerosis. J MolNeurosci. 2018;64(3):478\u201384. https:\/\/doi.org\/10.1007\/s12031-018-1046-x.","journal-title":"J MolNeurosci"},{"issue":"1","key":"1958_CR17","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.expneurol.2009.06.018","volume":"223","author":"EI Girolami","year":"2010","unstructured":"Girolami EI, Bouhy D, Haber M, Johnson H, David S. Differential expression and potential role of SOCS1 and SOCS3 in wallerian degeneration in injured peripheral nerve. Exp Neurol. 2010;223(1):173\u201382. https:\/\/doi.org\/10.1016\/j.expneurol.2009.06.018.","journal-title":"Exp Neurol"},{"key":"1958_CR18","doi-asserted-by":"publisher","unstructured":"Tesser A, Bocca P, Ulivi M, Pin A, Pastorino C, Cangelosi D, Santori E, Drago E, Caorsi R, Candotti F, Gattorno M. Type I interferon signature: a quantitative standardized method for clinical application. Clin Exp Immunol. 2025;219(1):uxaf018. https:\/\/doi.org\/10.1093\/cei\/uxaf018","DOI":"10.1093\/cei\/uxaf018"},{"issue":"3","key":"1958_CR19","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.1529-8027.2010.00271.x","volume":"15","author":"G Lauria","year":"2010","unstructured":"Lauria G, Bakkers M, Schmitz C, et al. Intraepidermal nerve fiber density at the distal leg: a worldwide normative reference study. J Peripher Nerv Syst. 2010;15(3):202\u20137. https:\/\/doi.org\/10.1111\/j.1529-8027.2010.00271.x.","journal-title":"J Peripher Nerv Syst"},{"key":"1958_CR20","doi-asserted-by":"publisher","unstructured":"Oliveira JB, Bleesing JJ, Dianzani U et al. Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop. Blood. 2010;116(14):e35-e40. https:\/\/doi.org\/10.1182\/blood-2010-04-280347","DOI":"10.1182\/blood-2010-04-280347"},{"issue":"10","key":"1958_CR21","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1084\/jem.20110428","volume":"208","author":"R Takahashi","year":"2011","unstructured":"Takahashi R, Nishimoto S, Muto G, et al. SOCS1 is essential for regulatory T cell functions by preventing loss of Foxp3 expression as well as IFN-{gamma} and IL-17A production. J Exp Med. 2011;208(10):2055\u201367. https:\/\/doi.org\/10.1084\/jem.20110428.","journal-title":"J Exp Med"},{"issue":"4","key":"1958_CR22","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1093\/hmg\/ddt489","volume":"23","author":"G Disanto","year":"2014","unstructured":"Disanto G, KjetilSandve G, Ricigliano VA, et al. DNase hypersensitive sites and association with multiple sclerosis. HumMolGenet. 2014;23(4):942\u20138. https:\/\/doi.org\/10.1093\/hmg\/ddt489.","journal-title":"HumMolGenet"},{"key":"1958_CR23","doi-asserted-by":"publisher","unstructured":"Lopez de Lapuente A, Pinto-Medel MJ, Astobiza I et al. Cell-specific effects in different immune subsets associated with SOCS1 genotypes in multiple sclerosis [published correction appears in MultScler. 2016;22(1):NP5. doi: 10.1177\/1352458515616913]. MultScler. 2015;21(12):1498\u20131512. https:\/\/doi.org\/10.1177\/1352458514566418","DOI":"10.1177\/1352458514566418"},{"issue":"7","key":"1958_CR24","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.cell.2023.03.008","volume":"186","author":"M Charabati","year":"2023","unstructured":"Charabati M, Wheeler MA, Weiner HL, Quintana FJ. Multiple sclerosis: neuroimmune crosstalk and therapeutic targeting. Cell. 2023;186(7):1309\u201327. https:\/\/doi.org\/10.1016\/j.cell.2023.03.008.","journal-title":"Cell"},{"issue":"5","key":"1958_CR25","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/ni.1716","volume":"10","author":"A Reboldi","year":"2009","unstructured":"Reboldi A, Coisne C, Baumjohann D, et al. C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat Immunol. 2009;10(5):514\u201323. https:\/\/doi.org\/10.1038\/ni.1716.","journal-title":"Nat Immunol"},{"issue":"5","key":"1958_CR26","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1007\/s10875-023-01460-4","volume":"43","author":"RC Hale","year":"2023","unstructured":"Hale RC, Owen N, Yuan B, Chinn IK, SOCS1 Study Group. Phenotypic variability of SOCS1 haploinsufficiency. J Clin Immunol. 2023;43(5):902\u20136. https:\/\/doi.org\/10.1007\/s10875-023-01460-4.","journal-title":"J Clin Immunol"},{"key":"1958_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1385190","volume":"15","author":"J K\u00f6rholz","year":"2024","unstructured":"K\u00f6rholz J, Chen LS, Strauss T, Schuetz C, Dalpke AH. One gene to rule them all - clinical perspectives of a potent suppressor of cytokine signaling - SOCS1. Front Immunol. 2024;15:1385190. https:\/\/doi.org\/10.3389\/fimmu.2024.1385190.","journal-title":"Front Immunol"},{"key":"1958_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1271102","volume":"14","author":"R Pandey","year":"2023","unstructured":"Pandey R, Bakay M, Hakonarson H. SOCS-JAK-STAT inhibitors and SOCS mimetics as treatment options for autoimmune uveitis, psoriasis, lupus, and autoimmune encephalitis. Front Immunol. 2023;14:1271102. https:\/\/doi.org\/10.3389\/fimmu.2023.1271102.","journal-title":"Front Immunol"},{"issue":"1","key":"1958_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04013-1","volume":"9","author":"NPD Liau","year":"2018","unstructured":"Liau NPD, Laktyushin A, Lucet IS, et al. The molecular basis of JAK\/STAT inhibition by SOCS1. Nat Commun. 2018;9(1):1558. https:\/\/doi.org\/10.1038\/s41467-018-04013-1.","journal-title":"Nat Commun"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-025-01958-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-025-01958-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-025-01958-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T08:30:09Z","timestamp":1777710609000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-025-01958-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1958"],"URL":"https:\/\/doi.org\/10.1007\/s10875-025-01958-z","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,18]]},"assertion":[{"value":"7 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original version of this paper was updated to correct the presentation of Genny Del Zotto's name.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all participants included in the study. In case of minor patients, written informed consent was obtained from the parents.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent To Participate"}},{"value":"Informed consent to publish was obtained from all participants included in the study. In case of minor patients, informed consent was obtained from the parents.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent To Publish"}},{"value":"\u00a0Nothing to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of generative AI in scientific writing"}},{"value":"The study protocol was approved by the Ethical board of the G. Gaslini Institute in Genova (Italy).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"SV received speaker\u2019s fee from SOBI and consultancies fee from Boehringer. RC received consultancy and speaker fee from SOBI. MG received consultancy and speaker fee from Novartis, Sobi, Fresenius Kabi, Kiniksa. Other authors declared no conflict of interest.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"165"}}